Trials / Conditions / Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8

Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8

13 registered clinical trials studyying Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8 — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	TMV Vaccine Therapy Alone and With Pembrolizumab for the Treatment of Recurrent and/or Metastatic Head and Nec NCT06868433	Emory University	Phase 1
Recruiting	Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin a NCT06662058	Emory University	N/A
Recruiting	Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected NCT06265285	Mayo Clinic	Phase 2
Withdrawn	Testing the Addition of an Investigational Drug, Xevinapant, to Usual Radiation Therapy Plus Cisplatin/Carbopl NCT06084845	ECOG-ACRIN Cancer Research Group	Phase 2
Withdrawn	Pilot Trial of E Cigarettes in Pts Diagnosed With Cancer of the Head, Neck, and Lung NCT05412875	Ohio State University Comprehensive Cancer Center	N/A
Active Not Recruiting	Combining Radiation Therapy With Immunotherapy for the Treatment of Metastatic Squamous Cell Carcinoma of the NCT05721755	ECOG-ACRIN Cancer Research Group	Phase 3
Active Not Recruiting	Testing the Addition of an Anti-cancer Drug, BAY 1895344, With Radiation Therapy to the Usual Pembrolizumab Tr NCT04576091	National Cancer Institute (NCI)	Phase 1
Recruiting	Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Soli NCT05269381	Mayo Clinic	Phase 1 / Phase 2
Active Not Recruiting	Sonidegib and Pembrolizumab in Treating Patients With Advanced Solid Tumors NCT04007744	Mayo Clinic	Phase 1
Completed	Abexinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumor Malignancies NCT03590054	Rahul Aggarwal	Phase 1
Active Not Recruiting	Cemiplimab in Treating Patients With Recurrent and Resectable Stage II-IV Head and Neck Cutaneous Squamous Cel NCT03565783	M.D. Anderson Cancer Center	Phase 2
Completed	Gabapentin, Methadone, and Oxycodone With or Without Venlafaxine Hydrochloride in Managing Pain in Participant NCT03574792	Roswell Park Cancer Institute	Phase 2
Active Not Recruiting	CIMAvax Vaccine, Nivolumab, and Pembrolizumab in Treating Patients With Advanced Non-small Cell Lung Cancer or NCT02955290	Roswell Park Cancer Institute	Phase 1 / Phase 2